臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52845775 線上人數 : 664 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yen shen lu"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 121-130 / 149 (共15頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-25T06:51:45Z	Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial	Ciruelos E.M; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.; Andr? F; Andr? F;Ciruelos E.M;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.
臺大學術典藏	2020-05-25T06:51:45Z	Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS	Chiu H.-H;Liao H.-W;Shao Y.-Y;Yen-Shen Lu;Lin C.-H;Tsai I.-L;Kuo C.-H.; Chiu H.-H; Liao H.-W; Shao Y.-Y; YEN-SHEN LU; Lin C.-H; Tsai I.-L; Kuo C.-H.
臺大學術典藏	2020-05-25T06:51:45Z	Effect of glucocorticoid use on survival in patients with stage I�VIII breast cancer	Tang C.-H.; Cheng A.-L; YEN-SHEN LU; Chao M; Wang M.-Y; Huang C.-S; Chiang C.-J; You S.-L; Chuang P.-Y; Lin C.-H;Chuang P.-Y;You S.-L;Chiang C.-J;Huang C.-S;Wang M.-Y;Chao M;Yen-Shen Lu;Cheng A.-L;Tang C.-H.; Lin C.-H
臺大學術典藏	2020-05-25T06:51:44Z	Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer	Chen B.-B;Yen-Shen Lu;Yu C.-W;Lin C.-H;Chen T.W.-W;Wei S.-Y;Cheng A.-L;Shih T.T.-F.; Chen B.-B; YEN-SHEN LU; Yu C.-W; Lin C.-H; Chen T.W.-W; Wei S.-Y; Cheng A.-L; Shih T.T.-F.
臺大學術典藏	2020-05-25T06:51:44Z	Survey of diet and physical activity in new cases of young breast cancer patients in Taiwan	Feng H; Chen H.-C; Chen I.-C; Lin C.-H; YEN-SHEN LU; Kuo W.-H; Wang M.-Y; Huang C.-S; Cheng A.-L; Chen W.-W; Chen P.-R.; Feng H;Chen H.-C;Chen I.-C;Lin C.-H;Yen-Shen Lu;Kuo W.-H;Wang M.-Y;Huang C.-S;Cheng A.-L;Chen W.-W;Chen P.-R.
臺大學術典藏	2020-05-25T06:51:44Z	Ribociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study	Im S.-A;Sohn J;Tripathy D;Chow L;Lee K.S;Jung K.H;Babu G;Im Y.-H;El Saghir N;Liu M.-C;Diaz-Padilla I;Alam J;Kong O;Miller M;Yen-Shen Lu; Im S.-A; Sohn J; Tripathy D; Chow L; Lee K.S; Jung K.H; Babu G; Im Y.-H; El Saghir N; Liu M.-C; Diaz-Padilla I; Alam J; Kong O; Miller M; YEN-SHEN LU
臺大學術典藏	2020-05-25T06:51:44Z	Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis	Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D.
臺大學術典藏	2020-05-25T06:51:44Z	Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients	Dai M.-S;Chao T.-Y;Chao T.-C;Chiu C.-F;Yen-Shen Lu;Shiah H.-S;Wu Y.-Y;Gerald Fetterly G;Hung N;Cutler D.L;Kwan R;Douglas Kramer D;Chan W.-K;Hung T.; Dai M.-S; Chao T.-Y; Chao T.-C; Chiu C.-F; YEN-SHEN LU; Shiah H.-S; Wu Y.-Y; Gerald Fetterly G; Hung N; Cutler D.L; Kwan R; Douglas Kramer D; Chan W.-K; Hung T.
臺大學術典藏	2020-05-25T06:51:43Z	Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer	Iwata H;Masuda N;Kim S.-B;Inoue K;Rai Y;Fujita T;Chiu J;Ohtani S;Takahashi M;Miyaki T;Yen-Shen Lu;Xu B;Yap Y.S;Bustam A;Yao B;Zhang B;Bryce R;Chan A.; Iwata H; Masuda N; Kim S.-B; Inoue K; Rai Y; Fujita T; Chiu J; Ohtani S; Takahashi M; Miyaki T; YEN-SHEN LU; Xu B; Yap Y.S; Bustam A; Yao B; Zhang B; Bryce R; Chan A.
臺大學術典藏	2020-05-25T06:51:43Z	Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer	Andr? F;Ciruelos E;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.; Andr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.

顯示項目 121-130 / 149 (共15頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目